Correlation Between Hansa Biopharma and Devyser Diagnostics
Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and Devyser Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and Devyser Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hansa Biopharma AB and Devyser Diagnostics AB, you can compare the effects of market volatilities on Hansa Biopharma and Devyser Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of Devyser Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and Devyser Diagnostics.
Diversification Opportunities for Hansa Biopharma and Devyser Diagnostics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Hansa and Devyser is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and Devyser Diagnostics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Devyser Diagnostics and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with Devyser Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Devyser Diagnostics has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and Devyser Diagnostics go up and down completely randomly.
Pair Corralation between Hansa Biopharma and Devyser Diagnostics
Assuming the 90 days trading horizon Hansa Biopharma AB is expected to generate 1.61 times more return on investment than Devyser Diagnostics. However, Hansa Biopharma is 1.61 times more volatile than Devyser Diagnostics AB. It trades about 0.03 of its potential returns per unit of risk. Devyser Diagnostics AB is currently generating about -0.29 per unit of risk. If you would invest 3,022 in Hansa Biopharma AB on September 13, 2024 and sell it today you would earn a total of 30.00 from holding Hansa Biopharma AB or generate 0.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hansa Biopharma AB vs. Devyser Diagnostics AB
Performance |
| Timeline |
| Hansa Biopharma AB |
| Devyser Diagnostics |
Hansa Biopharma and Devyser Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hansa Biopharma and Devyser Diagnostics
The main advantage of trading using opposite Hansa Biopharma and Devyser Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, Devyser Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Devyser Diagnostics will offset losses from the drop in Devyser Diagnostics' long position.| Hansa Biopharma vs. Oncopeptides AB | Hansa Biopharma vs. ExpreS2ion Biotech Holding | Hansa Biopharma vs. BioInvent International AB | Hansa Biopharma vs. Zealand Pharma AS |
| Devyser Diagnostics vs. Oncopeptides AB | Devyser Diagnostics vs. Hansa Biopharma AB | Devyser Diagnostics vs. Cantargia AB | Devyser Diagnostics vs. Camurus AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |